Cargando…
Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?
Despite the improved treatment of cardiovascular diseases, the population with end-stage heart failure (HF) is progressively growing. The scarcity of the gold standard therapy, heart transplantation, demands novel therapeutic approaches. For patients awaiting transplantation, ventricular-assist devi...
Autores principales: | Tseng, Cheyenne C. S., Ramjankhan, Faiz Z., de Jonge, Nicolaas, Chamuleau, Steven A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387859/ https://www.ncbi.nlm.nih.gov/pubmed/25905105 http://dx.doi.org/10.3389/fsurg.2015.00010 |
Ejemplares similares
-
Soluble ST2 in end‐stage heart failure, before and after support with a left ventricular assist device
por: Tseng, Cheyenne C. S., et al.
Publicado: (2018) -
Short-term mechanical support and pharmacotherapy, a new strategy in cardiogenic shock?
por: Tseng, C. C. S., et al.
Publicado: (2014) -
MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices
por: Lok, Sjoukje I., et al.
Publicado: (2015) -
Exosome-Mediated Angiogenesis Underlies LVAD-Induced Bleeding in Patients With End-Stage Heart Failure
por: Mone, Pasquale, et al.
Publicado: (2022) -
Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands: Towards LVAD destination therapy in the Netherlands?
por: Manintveld, O. C.
Publicado: (2014)